Philips enables digitization of tumor tissue research at Institut Curie to combat cancer

November 7, 2013

  • Creating virtual pathology laboratory for cancer research
  • Digital switchover allows sharing pathology images & knowledge among cancer research institutes


Paris, France – Philips today announced that it is collaborating with Institut Curie who is now able to digitize tumor analysis research, with the aim of speeding up and improving cancer diagnosis and treatment. Today pathologists view tissue sample images manually using a microscope. By using Philips Digital Pathology Solution, Institut Curie hopes to increase workflow efficiency and consolidate its pathology activities at multiple sites into one single virtual laboratory.


As well as the diagnosis of tissue from patients with cancer indications, the pathology department at Institut Curie evaluates thousands of test samples from experimental cancer research programs worldwide to gain a better understanding of the causes and mechanisms of diseases at both cellular and molecular level. These new insights may give rise to new diagnostic approaches and therapeutic treatments.


Currently, Institut Curie produces and diagnoses more than 200,000 glass pathology slides every year using a microscope. Digitalization of the pathology workflow could ease this logistical burden and enable new ways of working, such as real-time collaboration with peers and creation of a virtual network across the globe. Moreover, in cancer research digital histopathology information can now, for example, be added to biology data and this opens up new ways to mine information from tumor tissue for further data analysis.
”Digitalization of pathology will enable us to keep momentum going to accelerate cancer research and in the end improve patient’s care,” says Xavier Sastre-Garau, Director of the Biopathology Department of Institut Curie.

“Philips’ digital pathology solution is empowering Institut Curie to realize a single virtual laboratory that offers new opportunities for intensive collaboration,” says Guido du Pree VP Marketing & Sales of Philips Digital Pathology Solutions.


To support its cancer research, Insitut Curie has completed installation of the fully integrated Philips Digital Pathology Solution with ultrafast scanners at its locations in Paris and St. Cloud, which are connected on-line through an image management system that provides an interface to communicate with commercially available Laboratory Information Systems (LIS). Institut Curie benefited for this acquisition from the support of the National cancer Institute, SiRIC grant with reference « INCa-DGOS- 4654».

Philips Digital Pathology solution uses a ultra-fast scanner that digitizes the glass tissue slides.

Digitalization of pathology will enable Institut Curie to accelerate cancer research.

For further information, please contact:

Hans Driessen
Tel: +31 6 10610417


About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at